Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Mears Group acquires Care UK’s domiciliary care service for £11.3m

Support services firm Mears Group has bought Care UK’s home care division, as was first reported by HealthInvestor, for a sum of £11.3 million.

The purchase price comprises of a base payment of £9 million with a further payment of £2.3 million made in respect of cash balances and excess working capital acquired on completion.

Care UK’s home care service looks after approximately 13,000 people across the UK and employs around 6,000 staff members.

For the year ended 30 September 2014, it reported revenues of £72.2 million and an operating loss before exceptional items of £2.6 million.

In a statement, Mears said Care UK had already started closing some branches of the domiciliary care business because of “particularly poor results in certain regions”.

The acquired assets will be renamed Mears Care and the management team will remain the same.

David Miles, chief executive of Mears Group (pictured), said: "I believe we have acquired one of our most significant competitors at an attractive valuation. Our focus will be upon enhancing service delivery thus enabling financial improvements.”

The acquisition  marks the completion of Care UK’s divestment strategy, which also saw it sell off its mental health and learning disability divisions. The private care provider has said it plans focus solely primary and secondary NHS health services and residential and nursing homes.

In May, Care UK sold its mental health assets, comprising of 322 beds, to Partnerships in Care for an undisclosed sum. It also sold its learning disability services group to Lifeways in the same month.

According to a press release, the three transactions, which had a combined annual ebitda of £12.9 million last year, have generated £130 million (before fees and expenses) for Care UK.

Mike Parish, chief executive of Care UK, said: “We are pleased to have reached very positive outcomes for patients and services users, colleagues and commissioners in all three services. The strategic review process which is now completed strengthens Care UK’s positioning for future growth within both the health and social care sectors.”

Rothschild advised Care UK on its divestments.


Related articles:

Posted on: 01/06/2015

Latest news stories

16/11/2018
Care provider Regard Group has appointed Tracy Kite (pictured) as director of learning and leadership development.
15/11/2018
The McAvoy Group has been awarded a £15 million contract for the offsite construction of a new wing at Northumbria Specialist Emergency Care Hospital, Cramlington.
14/11/2018
Independent investment manager Albion Capital has invested £5 million in The Evewell, a fully-integrated medical centre specialising in reproductive and gynaecological health.
14/11/2018
Investment banking firm Jefferies has published its inaugural ‘Jefferies Healthcare Temperature Check’ – presenting the views of nearly 500 senior leaders within the healthcare sector.
14/11/2018
In an interview with HSJ, health secretary Matt Hancock has said that the government is “not going to hand [integrated care contracts] to the big private healthcare companies”.


Civica


HealthInvestor blog
The Care Quality Commission is finding its voice as a regulator, but is anyone listening?

Click here to view the HealthInvestor blog


An interest in people rather than machines led to Andrew Lennox dedicating his career to improving patient outcomes
The Care Quality Commission’s latest summary of the state of health and social care points to an unfair and fragmented system
Echo co-founder Stephen Bourke tells Jack Carter how his app is simplifying the repeat prescription process
With the care village market still very much in its infancy in the UK, perhaps two of the biggest questions facing every care village developer, investor and operator are how much can we sell our care village apartments for, and will they hold their value? Carterwood director Ben Hartley provides some answers
Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners

Click here to search all feature articles



Deal in the spotlight

Elysium Healthcare's acquisition of LCP takes the group portfolio to more than 60 homes in just two years
Read more


Christie + Co

my images



Veterinary

Vet sector consolidation means the risk of CMA intervention is increasing, say Andrew Taylor and Nick Warren, partners at Aldwych Partners
Read more